ArticleThe oncologist2025

Prolonged response to PIK3CA inhibition in an advanced hormone-positive breast cancer patient with 3 mutations in the alpha subunit of PI-3 kinase.

Rotem Merose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.